Search

everythinglearnresearchcommunity

for

Search:↓

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Male hormones worsen kidney transplant damage, but blocking them helps.

LncRNA MTC boosts growth of goat skin cells, improving cashmere quality.

Sex hormones affect dog skin conditions, but more data is needed.

Hair loss in men is common, treatable, but not curable.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Rats had lasting erectile problems after stopping a certain medication.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hormones and genes affect hair growth and male baldness.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Using existing drugs for new treatments is cost-effective and safer.